Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > lets sell ATE

<< Previous

Bullboard Posts

Next >>

Comment by SunsetGrillon Mar 11, 2021 6:59pm

135 Views

Post# 32782052

RE:RE:lets sell ATE

SOooooooo. Easy solution if $5 is a no brainer then buy 100,000 shares or more today at 4.75 (or lower) for an easy 25K (or more) in the bank. And then quit whining

Layth1990 wrote: I'm bashing it after almost 3 years at 5 cad. Still couldn't excute all my shares at that price. Cannacord is talking profit on our backs. Thanks to clueless or more corrupted CEO. In short, if you don't take slight profit , they will. I will buy back if ceo is gone, i'm done with his sh**

<< Previous

Bullboard Posts

Next >>

Bitcoin Well increases reserve amid strong subscriber growth